Table 1.
Measurea | Elias et al. | Present study |
---|---|---|
Study period | Nov 1997 to Feb 2011 | Jan 1 to Dec 1 2009 |
ICU admissions, (n) | 92,866 | 90,733 |
Patients, (n) | 92,886 | 77,040 |
Hospitals, (n) | 2 | 151 |
Patient age (years), mean (SD) | 61.6 (17.7) | 74.2 (12.2) |
Male, n (%) | 53,658 (57.7) | 44,207 (48.7) |
Nonwhite race n (%) | 18,762 (20.2) | 10,406 (11.5) |
Patient type, n (%) | ||
Medical | 46,683 (50.3) | 52,789 (58.2) |
Charlson Comorbidity Index, n (%) | ||
0 – 1 | 35,277 (38.0) | 47,327 (52.2) |
2 – 3 | 31,587 (34.0) | 31,880 (35.1) |
4 – 6 | 20,907 (22.5) | 9,505 (10.5) |
≥7 | 5,115 (5.5) | 2,021 (2.2) |
Elixhauser Index, median (IQR) | n/a | 3 (2,4) |
COPS2, median (IQR) | n/a | 46 (19,70) |
Sepsis, n (%) | 11,602 (12.5) | 10,872 (12.0) |
Acute organ failure type, n (%) | ||
Hematologic | 8,544 (9.2) | 2,260 (2.5) |
Hepatic | 1,658 (1.8) | 905 (1.0) |
Metabolic | 3,759 (4.0) | 4,319 (4.8) |
Neurologic | 6,741 (7.3) | 3,459 (3.8) |
Renal | 11,669 (12.6) | 14,716 (16.2) |
Respiratory | 27,288 (29.4) | 12,145 (13.4) |
Hospital LOS (days), mean (SD) | 12 (14.5) | 9.8 (9.9) |
30-day mortality, n (%) | 11,721 (12.6) | 15,995 (17.6) |
p<0.05 for comparisons of all patient-level factors between the original and present study cohorts
SD, standard deviation; IQR, interquartile range; COPS2, COmorbidity Point Score; LOS, length of stay